Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Genetically modified Lactococcus lactis bacteria containing the human trefoil factor 1 gene

EU orphan designation number: EU/3/11/903   
Active ingredient: Genetically modified Lactococcus lactis bacteria containing the human trefoil factor 1 gene
Indication: Prevention of oral mucositis in head and neck cancer patients undergoing radiation therapy
Sponsor: ActoGeniX N.V.
Technologiepark 4, B-9052 Zwijnaarde, België

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
29/09/2011 Centralised Orphan - Designation EMA/OD/027/11 (2011)7036 of 27/09/2011